跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
18F-FDG-PET
首页
药物
18F-FDG-PET
18F-FDG-PET
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
USE OF POSITRON MYOCARDIAL FATTY ACID METABOLISM IMAGING AGENT AND POSITRON 18F-FDG MYOCARDIAL GLUCOSE IMAGING AGENT IN PET COMBINED IMAGING
申请人: BEIJING SINOTAU INTERNATIONAL PHARMACEUTICAL TECH CO LTD
优先权: 2023
CN
EP
US
WO
5 件公开
Reagent for detecting breast cancer axillary lymph node metastasis and application thereof
申请人: GENERAL HOSPITAL OF EASTERN THEATER COMMAND OF THE CHINESE PEOPLES LIBERATION ARMY
优先权: 2021
CN
In vivo positron emission tomography-based perfusion/blood pool imaging using labeled erythrocytes
申请人: H LEE MOFFITT CANCER CT & RES
优先权: 2017
US
Preparation method of diagnosis and treatment integrated preparation based on PET-CT (positron emission tomography-computed tomography) and application of diagnosis and treatment integrated preparation in tumor treatment
申请人: UNIV TIANJIN TECHNOLOGY
优先权: 2024
CN
Purification column for purifying positron radiopharmaceuticals 18F-FDG (fluorodeoxyglucose)
申请人: WUXI JIANGYUAN IND TECHNOLOGY AND TRADE CORPERATION
优先权: 2011
CN
Novel bimodal PET/CT imaging material as well as preparation method and application thereof
申请人: NINGBO HUAMEI HOSPITAL UNIV OF CHINESE ACADEMY OF SCIENCES
优先权: 2020
CN
一种对不同肺癌细胞具有选择性的PET/CT示踪剂及其制备方法和用途
申请人: 四川大学华西医院
优先权: 2019
CN
Application of 18F-FAPI-42 in preparation of product for diagnosing lung lymphangioleiomyomatosis
申请人: THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV GUANGZHOU RESPIRATORY CENTER
优先权: 2024
CN
药物
反馈